NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/21/2025
Back to search
Official data from USPTO
CLOAKED THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLOAKED THERAPEUTICS
ST13
US500000086400613Class
5
Filing
86400613
Registration
4893522
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/22/2025
Trademark type
Word
Nice classes
5
Filing date
09/19/2014
Registration date
01/26/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/21/2025
Last transaction
08/22/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/19/2014
First use in commerce
09/19/2014
Drawing code
4
Owner type
16
Owner location
ETTA, MS
Examiner
ANDERSON, CASSONDRA CR
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VEILED THERAPEUTICS, LLC
A. T. (pessoa física)
Representatives
Tiffany D. Gehrke Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/21/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/21/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/16/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
04/11/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/26/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/12/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/12/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/06/2023
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
07/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/05/2022
ES8R
TEAS SECTION 8 RECEIVED
01/27/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/22/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/21/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/02/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2015
IUAF
USE AMENDMENT FILED
11/05/2015
EISU
TEAS STATEMENT OF USE RECEIVED
11/05/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/05/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2015
PUBO
PUBLISHED FOR OPPOSITION
03/10/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/18/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/02/2015
ALIE
ASSIGNED TO LIE
01/28/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
01/07/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/07/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
01/07/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/07/2015
DOCK
ASSIGNED TO EXAMINER
01/05/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2014
NWAP
NEW APPLICATION ENTERED
09/23/2014
Continuous trademark protection
Get notified about every new filing that threatens CLOAKED THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.